Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Resistance”

868 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 868 results

Early research (Phase 1)UnknownNCT03050411
What this trial is testing

Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer

Who this might be right for
Nonsmall Cell Lung Cancer
Peking University Third Hospital 30
Testing effectiveness (Phase 2)Study completedNCT05685615
What this trial is testing

PK of BV100 in Patients VABP Suspected or Confirmed to Be Due to CRAB

Who this might be right for
Ventilator Associated Pneumonia
BioVersys AG 39
Not applicableStudy completedNCT02709408
What this trial is testing

European Prospective Cohort Study on Enterobacteriaceae Showing Resistance to Carbapenems

Who this might be right for
Carbapenem Resistant Bacteria Infection
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 2,515
Not applicableStudy completedNCT05812976
What this trial is testing

Novel Index (PIMR) in PAH

Who this might be right for
Pulmonary Hypertension
University of California, Los Angeles 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06537297
What this trial is testing

Intrathecal Pemetrexed Combined With High-dose Furmonertinib and Beva for EGFR-m NSCLC With Leptomeningeal Metastases

Who this might be right for
Non-small Cell Lung Cancer
Hunan Province Tumor Hospital 30
Large-scale testing (Phase 3)Study completedNCT00933790
What this trial is testing

Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis

Who this might be right for
HIV InfectionPulmonary TB
Tuberculosis Research Centre, India 331
Testing effectiveness (Phase 2)Ended earlyNCT02025218
What this trial is testing

Iressa Re-challenge in Advanced NSCLC EGFR-mutated Patients

Who this might be right for
Lung Cancer
Amsterdam UMC, location VUmc 21
Early research (Phase 1)Not Yet RecruitingNCT07702305
What this trial is testing

Safety and Efficacy of Intrathecal Sacituzumab Tirumotecan for Leptomeningeal Metastasis in EGFR-TKI-Resistant Non-Small Cell Lung Cancer

Who this might be right for
EGFR-TKI-resistant Non-small Cell Lung Cancer With Leptomeningeal Metastasis
Henan Cancer Hospital 15
Testing effectiveness (Phase 2)Study completedNCT06478953
What this trial is testing

Impact of Rapid Pathogen Detection in ICU Patients With Suspected Pneumonia on Antimicrobial Therapy

Who this might be right for
PneumoniaCritically Ill
Chinese University of Hong Kong 40
Not applicableUnknownNCT06483529
What this trial is testing

Respiratory Mechanics Measurement of Ventilated Patients Through Low-frequency Oscillometry Technique

Who this might be right for
Ventilator Lung
Universitair Ziekenhuis Brussel 21
Testing effectiveness (Phase 2)Looking for participantsNCT07189871
What this trial is testing

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more
Radiopharm Theranostics, Ltd 61
Not applicableLooking for participantsNCT05049837
What this trial is testing

PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification

Who this might be right for
Lung CancerCancer of Thorax
M.D. Anderson Cancer Center 7,200
Early research (Phase 1)Study completedNCT07097727
What this trial is testing

Evaluation of the Role of Acetyl Cysteine in Ventilator Associated Pneumonia by Carbapenem Resistance Klebsiella

Who this might be right for
Ventilator Associated Pneumonia ( VAP)Mechanical Ventilation
Tanta University 70
Not applicableStudy completedNCT04118257
What this trial is testing

Short-term Sugary Beverage Consumption on Glucose Control and Cardiovascular Disease Risk Factors

Who this might be right for
Metabolic Syndrome
Kansas State University 37
Testing effectiveness (Phase 2)Study completedNCT00284141
What this trial is testing

Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma

Who this might be right for
Pulmonary DiseasesNeoplasms, Lung
Sanofi 98
Very early researchNot Yet RecruitingNCT07498595
What this trial is testing

TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC

Who this might be right for
EGFR-TKI-resistant Non-Small Cell Lung Cancer
Tianjin Medical University General Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT06630611
What this trial is testing

Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)

Who this might be right for
MelanomaNon Small Cell Lung CancerCervical Cancer
Vall d'Hebron Institute of Oncology 40
Early research (Phase 1)Study completedNCT05585034
What this trial is testing

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more
Xencor, Inc. 60
Not applicableUnknownNCT02661009
What this trial is testing

Human EGFR Mutations Quantitative Detection Kit (Real-time Fluorescent PCR Method)

Who this might be right for
Non Small Cell Lung CancerEGFR-TKI Resistant MutationEGFR-TKI Sensitizing Mutation
GenoSaber 1,000
Not applicableUnknownNCT04203095
What this trial is testing

Chromosomal Instability as a Surrogate Biomarker of Drug Resistance in Immunotherapy for Lung Cancer Patients

Who this might be right for
Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 40
Next Page